Do no harm: Avoidance of herbal medicines during pregnancy

Obstetrics and Gynecology

Volumn 105, Issue 5, 2005, Pages 1119-1122

  Marcus, Donald M ^a   Snodgrass, Wayne R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; COMFREY EXTRACT; CONIUM MACULATUM EXTRACT; DIETHYLSTILBESTROL; EPHEDRA EXTRACT; GINGER EXTRACT; GUM TRAGACANTH; INDOMETACIN; KAVA EXTRACT; PLANT EXTRACT; PYRIDOXINE; SILDENAFIL; TADALAFIL; VERATRUM ALKALOID; WARFARIN;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM ULCER; DRUG SAFETY; EMBRYO; EMBRYO DEATH; FETUS RISK; GINGER; HEALTH CARE PERSONNEL; HEPATITIS; HERBAL MEDICINE; HUMAN; KIDNEY BLOOD FLOW; LACTATION; LIVER FAILURE; MEDICAL SOCIETY; NONHUMAN; PREGNANCY; PREGNANCY DISORDER; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; REVIEW; TERATOLOGY; TRADITIONAL MEDICINE; UROGENITAL TRACT CANCER;

FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; MEDICINE, HERBAL; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT;

EID: 17644365460     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000158858.79134.ea     Document Type: Editorial

References (30)

1. Finkel RS, Zarlengo KM. Blue cohosh and perinatal stroke. N Engl J Med 2004;351:302-3.
2. Jones TK, Lawson BM. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr 1998;132:550-2.
3. U.S. Food and Drug Administration. Dietary supplements: overview. Available at: http://www.cfsan.fda.gov/∼dms/supplmnt.html. Retrieved February 18, 2005.
4. Nausea and vomiting of pregnancy. ACOG Practice Bulletin No. 52. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;103:803-15.
5. DeAngelis CD, Fontanarosa PB. Drugs alias dietary supplements. JAMA 2003;290:1519-20.
6. Garrard J, Harms S, Eberly LE, Matiak A. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Intern Med 2003;163:2290-5.
7. Cole MR, Fetrow CW. Adulteration of dietary supplements. Am J Health Syst Pharm 2003;60:1576-80.
8. Sovak M, Seligson AL, Konas M, Hajduch M, Dolezal M, Machala M, et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 2002;94:1275-81.
9. U.S. Food and Drug Administration. FDA advises dietary supplement manufacturers to remove comfrey products from the market. Available at: http://www.cfsan.fda.gov/∼dms/dspltr06.html. Retrieved February 18, 2005.
10. Hepatic toxicity possibly associated with kava-containing products—United States, Germany, and Switzerland 1999-2002. MMWR Morb Mortal Wkly Rep 2002;51:1065-7.
11. Swanepoel C, Naicker S., Moosa R, Katz I, Suleiman SM, Twahir M. Nephrotoxins in Africa. In: De Broe ME, Porter GA, Bemmett WB, Verpooten GA, editors. Clinical nephrotoxins: renal injury from drugs and chemicals. 2nd ed. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2003. p. 603-10.
12. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-77.
13. Cosyns JP. Aristolochic acid and “Chinese herbs nephropathy”: a review of the evidence to date. Drug Saf 2003;26:33-48.
14. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91.
15. Nortier JL, Martinez MM, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92.
16. Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen sold on the web after FDA alert. N Engl J Med 2003;349:1576-77.
17. Friedman JM. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 2000;62:134-7.
18. Smith C, Crowther C, Willson K, Hotham N, McMillian V. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol 2004;103:639-45.
19. Wilkinson JM. Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reprod Toxicol 2000;14:507-12.
20. Weidner MS, Sigwart K. Investigation of the teratogenic potential of a Zingiber officinale extract in the rat. Reprod Toxicol 2001;15:75-80.
21. Banerjee S, Sharma R, Kale RK, Rao AR. Influence of certain essential oils on carcinogen-metabolizing enzymes and acid-soluble sulfhydryls in mouse liver. Nutr Cancer 1994;21:263-9.
22. Miyoshi N, Nakamura Y, Ueda Y, Abe Y, Ozawa Y, Uchida K, et al. Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in human T lymphoma Jurkat cells. Cancer Lett 2003;199:113-9.
23. Backon J. Ginger in preventing nausea and vomiting of pregnancy: a caveat due to its thromboxane synthetase activity and effect on testosterone binding. Eur J Obstet Gynecol Reprod Biol 1991;42:163-4.
24. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene synthesis by gingerols and diarylheptanoids. Chem Pharm Bull 1992;40:387-91.
25. Verma SK, Singh J, Khamesra R, Bordia A. Effect of ginger on platelet aggregation in man. Indian J Med Res 1993;98:240-2.
26. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000;84:367-71.
27. Morris CA, Avorn J. Internet marketing of herbal products. JAMA 2003;290:1505-9.
28. Widespread ignorance of regulation and labeling of vitamins, minerals and food supplements, according to a National Harris Interactive Survey. Available at: http://www.harrisinteractive.com/news/allnewsbydate.asp?NewsID=560. Retrieved February 18, 2005.
29. American Society of Health-System Pharmacists. ASHP statement on the use of dietary supplements. Am J Health Syst Pharm 2004;61:1707-11.
30. Jurgens TM. Potential toxicities of herbal therapies in the developing fetus. Birth Defects Res B Dev Reprod Toxicol 2003;68:496-8.